EUVIMEDEUVIMED entdecken
Crossref

Establishment and application of drug utilization evaluation applying the weighted TOPSIS method: A study based on real-world data of tislelizumab

Yang Li, Qianxi Chen, Tao Zhu, Shaohuan Lu, Canhua Liang, Guangzhao Wang, Xuefeng Wu, Guangyi Meng

Technology and Health Care · 12.07.2024 · 32 (4) · 2619-2628

DOI: 10.3233/thc-231574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology and Health Care, erschienen am 12.07.2024. Verfasst von Yang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, China. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: How to comprehensively evaluate the rationality of drug use is a challenging issue. OBJECTIVE: To establish the evaluation index of the effective use of tislelizumab, so as to ensure its higher rationality and normalization in clinical application. METHODS: Based on the indications, drug instructions, and relevant guidelines of the National Basic Medical Insurance Restriction Catalogue, a retrospective analysis and evaluation of 286 cases of using tislelizumab injection in our hospital from January to December 2022 were conducted using the weighted technique for order of preference by similarity to ideal solution (TOPSIS) method. RESULTS: Among the 286 medical records evaluated, the main irrational manifestations were inappropriate indications (90 cases, 31.47%), auxiliary examination and laboratory examination did not meet the minimum requirements of combination chemotherapy drugs (40 cases, 13.99%), the drug course was not standard (39 cases, 13.64%). Among the included cases, 57.34% were reasonable cases (Ci⩾ 0.8), 10.84% were basic reasonable cases (0.6 ⩽Ci< 0.8), and 31.82% were unreasonable cases (Ci< 0.6). CONCLUSION: The TOPSIS method, with its attribute hierarchical model (AHM)-weighted approach, can be employed as the rational assessment technique for the injection of tislelizumab. The clinical application of tislelizumab in our hospital is still insufficient, which needs to be further improved management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedHumansRetrospective StudiesFemaleMaleMiddle AgedDrug UtilizationAdultAged

Stichwörter der Autor:innen

Drug use evaluationTislelizumabattribute hierarchical modelweighted TOPSIS

Substanzen

Antibodies, Monoclonal, Humanizedtislelizumab

Autor:innen und Institutionen

  • Department of Pharmacy, Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, China.
  • Guilin Medical University, Guilin, Guangxi, China.

Zitieren

APA

Li, Y., Chen, Q., Zhu, T., Lu, S., Liang, C., Wang, G., Wu, X., & Meng, G. (2024). Establishment and application of drug utilization evaluation applying the weighted TOPSIS method: A study based on real-world data of tislelizumab. Technology and Health Care, 32(4), 2619-2628. https://doi.org/10.3233/thc-231574

Vancouver

Li Y, Chen Q, Zhu T, Lu S, Liang C, Wang G, et al. Establishment and application of drug utilization evaluation applying the weighted TOPSIS method: A study based on real-world data of tislelizumab. Technology and Health Care. 2024;32(4):2619-2628. doi:10.3233/thc-231574

BibTeX
@article{Li2024,
  author = {Li, Yang and Chen, Qianxi and Zhu, Tao and Lu, Shaohuan and Liang, Canhua and Wang, Guangzhao and Wu, Xuefeng and Meng, Guangyi},
  title = {Establishment and application of drug utilization evaluation applying the weighted TOPSIS method: A study based on real-world data of tislelizumab},
  journal = {Technology and Health Care},
  year = {2024},
  volume = {32},
  number = {4},
  pages = {2619--2628},
  doi = {10.3233/thc-231574}
}
Kostenlos starten →